The Patent Finder

Amine Functional Polyamides

Genzyme Corporation

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 4 of these applications claim priority to application PCT/US2014/025384, filed Mar 13, 2014. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,682,975Method of Preparing Glucosylceramide Synthase Inhibitors
In force
 · High confidence
Genzyme CorporationIn force
High confidence
US 10,065,949Method of Preparing Glucosylceramide Synthase Inhibitors
In force
 · High confidence
Genzyme CorporationIn force
High confidence
US 10,604,518Method of Preparing Glucosylceramide Synthase Inhibitors
In force
 · High confidence
Genzyme CorporationIn force
High confidence
US 10,954,230Method of Preparing Glucosylceramide Synthase Inhibitors
In force
 · High confidence
Genzyme CorporationIn force
High confidence
US 9,326,994Amine Functional Polyamides
In force
 · High confidence
Genzyme CorporationIn force
High confidence
US 9,518,049Salt Forms of (S)-QUINUCLIDIN-3-YL (2-(2-(4-Fluorophenyl)THIAZOL-4-YL)PROPAN-2-YL)CARBAMATE
In force
 · High confidence
Genzyme CorporationIn force
High confidence
US 10,028,731Barrier Application Device
In force
 · High confidence
Baxter International Inc. and Baxter Healthcare S.A.In force
High confidence
US 10,113,032Amine Functional Polyamides
Lapsed Oct 30, 2026 on the fee record
Low confidence
Genzyme CorporationLapsed Oct 30, 2026 on the fee record
Low confidence
Application 14/776,059Sequestrants of Advanced Glycation End Product (AGE) Precursors
Abandoned
Abandoned Jan 22, 2018
Genzyme CorporationAbandonedAbandoned Jan 22, 2018
Application 15/038,185Novel Methods for Treating Neurodegenerative Diseases
Abandoned
Abandoned Oct 28, 2017
Genzyme CorporationAbandonedAbandoned Oct 28, 2017
4 more patents in this group · Pro
10 of 14 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 14, including 1 expired.
Upgrade to Pro
6 of these are in force and held by Genzyme Corporation.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited